Purchase Order 75N94022P00686

Award Date 8/22/22
Potential Completion Date 9/26/22
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health's National Institute of Child Health and Human Development (NICHD) awarded a $218,900.00 firm-fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for RNA sequencing services. Novogene has previously received over 100 prime contracts from federal agencies including the Department of Veterans Affairs, Department of Agriculture, and National Oceanic and Atmospheric Administration to provide genomic sequencing and bioinformatics...
Novogene Corp Inc., a minority-owned small business, has been awarded a $13,982 firm fixed price purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide RNA sequencing services in Bethesda, Maryland. The sequencing will support the agency's biomedical research efforts. As a prime contractor supporting multiple federal agencies, Novogene has over 100 contracts to conduct genomic sequencing and analysis for studies into diseases,...
This federal contract award is for $143,850.00 to Novogene Corp Inc., a minority-owned small business, by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse. The contract is a firm fixed price purchase order for genomic sequencing and bioinformatics services to support biomedical research. Novogene has previously received over 100 prime contracts from federal agencies including the NIH, Department of Veterans Affairs, Department of...
Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order contract valued at $24,350 by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for laboratory testing services to support genomic sequencing and bioinformatics research efforts. Specifically, Novogene will provide DNA/RNA sample sequencing and data analysis services leveraging Illumina and PacBio platforms, including whole...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $24,577.00 firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for DNA and RNA sequencing services. This contract is set aside for small businesses. Novogene is a provider of next-generation sequencing technologies that has delivered services to support various federal agencies' biomedical, agricultural, environmental, and basic...
The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $15,100 firm fixed price purchase order to Novogene Corp Inc. to provide RNA sequencing services in support of other functions. The work will be performed in Bethesda, Maryland over a three week period concluding on September 30, 2016. The contract was awarded directly without being associated with a larger government-wide acquisition contract vehicle or...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for RNA sequencing services. The $13,410.00 contract has a completion date of June 30, 2024. Novogene is a provider of next-generation sequencing technologies and has delivered sequencing and bioinformatics services to support biomedical research across various federal...
This is a $13,400 firm fixed-price purchase order contract awarded by the National Eye Institute, a civilian agency within the National Institutes of Health, to Novogene Corp Inc., a minority-owned small business. The contract is for cell handling and sequencing services, with a period of performance through September 30, 2024. Novogene is a genomics services provider that specializes in next-generation DNA and RNA sequencing, bioinformatics, and research support for federal agencies across...
This firm fixed-price purchase order in the amount of $72,600.00 was awarded by the National Institute of Child Health and Human Development (NICHD) to Novogene Corporation Inc., a minority-owned small business, for whole exome sequencing services. The award is for an ongoing project focused on identifying new genetic causes of adrenal and pituitary tumors and analyzing the effects of such genetic alterations. The effort involves DNA library preparation, sequencing, and customized bioinformatics...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $10,880 contract has a completion date of December 11, 2024 and was not set aside. Novogene is a provider of genomic sequencing and bioinformatics services, supporting various federal agencies' biomedical, agricultural, environmental, and basic research efforts. This award...

This contract was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $19,916.50, is for RNA sequencing services and was awarded to Novogene Corp Inc., a minority-owned small business that specializes in next-generation sequencing and bioinformatics.

Novogene has a significant track record of providing genomic services to various federal agencies, including the National Institutes of Health, Department of Veterans Affairs, Department of Agriculture, and the U.S. Geological Survey. This contract is not a set-aside, and the period of performance runs through September 26, 2022. Novogene's expertise in areas such as whole genome, exome, transcriptome, and metagenomic sequencing, as well as its established relationships with federal customers, likely contributed to its selection for this award.

Generated 10/11/24, 9:23 AM